APP and familial Alzheimer disease: To investigate whether F. mume mitigates cognitive impairments in AD, we used 5XFAD transgenic mice co-overexpressing human amyloid precursor protein (APP) and presenilin-1 (PS1) with five familial AD (FAD) mutations.